A detailed history of Price T Rowe Associates Inc transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 5,439,657 shares of SMMT stock, worth $106 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,439,657
Previous 2,042,100 166.38%
Holding current value
$106 Million
Previous $15.9 Million 647.83%
% of portfolio
0.01%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.89 - $31.93 $23.4 Million - $108 Million
3,397,557 Added 166.38%
5,439,657 $119 Million
Q2 2024

Aug 14, 2024

BUY
$2.39 - $10.92 $4.8 Million - $21.9 Million
2,008,955 Added 6061.11%
2,042,100 $15.9 Million
Q1 2024

May 15, 2024

BUY
$2.55 - $5.07 $13,104 - $26,054
5,139 Added 18.35%
33,145 $138,000
Q4 2023

Feb 14, 2024

BUY
$1.67 - $2.83 $1,768 - $2,996
1,059 Added 3.93%
28,006 $74,000
Q3 2023

Nov 14, 2023

BUY
$1.54 - $2.42 $5,289 - $8,312
3,435 Added 14.61%
26,947 $51,000
Q2 2023

Aug 14, 2023

BUY
$1.32 - $2.81 $31,035 - $66,068
23,512 New
23,512 $60,000

Others Institutions Holding SMMT

About Summit Therapeutics Inc.


  • Ticker SMMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 201,215,008
  • Market Cap $3.92B
  • Description
  • Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...
More about SMMT
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.